Doptelet Approved for Liver Disease Patients Slated for a Medical Procedure
MONDAY, May 21, 2018 -- Doptelet (avatrombopag) has been approved by the U.S. Food and Drug Administration to treat adults with chronic liver disease who are slated to have a medical or dental procedure.
People with ongoing liver disease often have...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Food and Drug Administration (FDA) | General Medicine | Liver | Liver Disease | Urology & Nephrology